Efficacy and prognosis of adjuvant treatment of endometrial cancer with medroxyprogesterone acetate COX regression analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

863

Tables (1-3)

186

Sum=1231

Publishing Process of This Article

Item

Count

Browse

Download

341

Sum=432

Aug 16, 2023 (publication date) through Aug 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 16, 2023; 11(23): 5447-5454
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5447

Table 3 Factors influencing the prognosis of patients with early-stage high-risk endometrial cancer

Citation: Wang DR. Efficacy and prognosis of adjuvant treatment of endometrial cancer with medroxyprogesterone acetate COX regression analysis. World J Clin Cases 2023; 11(23): 5447-5454
URL: https://www.wjgnet.com/2307-8960/full/v11/i23/5447.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i23.5447